Compass Therapeutics, Inc. Quarterly Current Ratio in % from Q4 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Compass Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q4 2018 to Q2 2024.
  • Compass Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 2.09K %, a 43.9% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 2.09K +636 +43.9% Jun 30, 2024
Q1 2024 2.14K +815 +61.4% Mar 31, 2024
Q4 2023 1.8K +508 +39.5% Dec 31, 2023
Q3 2023 1.56K +213 +15.8% Sep 30, 2023
Q2 2023 1.45K +281 +24% Jun 30, 2023
Q1 2023 1.33K +356 +36.6% Mar 31, 2023
Q4 2022 1.29K +618 +92.1% Dec 31, 2022
Q3 2022 1.35K +928 +222% Sep 30, 2022
Q2 2022 1.17K +697 +148% Jun 30, 2022
Q1 2022 972 +459 +89.3% Mar 31, 2022
Q4 2021 671 +114 +20.5% Dec 31, 2021
Q3 2021 419 -66.4 -13.7% Sep 30, 2021
Q2 2021 472 +39.8 +9.21% Jun 30, 2021
Q1 2021 514 +254 Mar 31, 2021
Q4 2020 557 +296 +114% Dec 31, 2020
Q3 2020 485 +480 Sep 30, 2020
Q2 2020 432 +426 Jun 30, 2020
Q1 2020 260* +252 Mar 31, 2020
Q4 2019 261 +254 Dec 31, 2019
Q3 2019 4.78* Sep 30, 2019
Q2 2019 5.96* Jun 30, 2019
Q1 2019 7.81* Mar 31, 2019
Q4 2018 7.01* Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.